Tech Company Financing Transactions
Gem Pharmaceuticals Funding Round
Gem Pharmaceuticals, based in Birmingham, secured $4.5 million in funding from private investors.
Transaction Overview
Company Name
Announced On
3/20/2014
Transaction Type
Venture Equity
Amount
$4,500,000
Round
Undisclosed
Investors
private investors (Diane Hendricks)
private investors (Karl Leo)
Proceeds Purpose
The company intends to use the funds for the upcoming Phase 2 clinical trial of GPX-150 in sarcoma patients.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
941 Lake Forest Cir.
Birmingham, AL 35244
USA
Birmingham, AL 35244
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Gem Pharmaceuticals, LLC, is a clinical-stage biopharmaceutical company developing proprietary anthracycline derivatives.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Arthur Klausner
Chief Medical Officer
Robert Vestal
Chief Operating Officer
Gerald Walsh
Chief Scientific Officer
Richard Olson
Browse more venture capital transactions:
Prev: 3/20/2014: Coupa Software venture capital transaction
Next: 3/20/2014: ClearEdge Power venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs